A Simple Shot May Guard Kids From Malaria Longer

Kids in many places get malaria a lot. Doctors give them medicine to stop the disease before it starts. The usual mix is sulfadoxine-pyrimethamine plus amodiaquine, called SP-AQ. But germs are getting tougher to beat, and kids sometimes miss doses. This makes scientists look for better options.

Scientists are testing a new drug named cabamiquine. It works on the parasite in the liver and in the blood. It is taken just one time. They pair it with another medicine called pyronaridine. Together they hope to give longer protection. The goal is to stop malaria before it makes kids sick.

Using computer models, researchers looked at how the drug pair behaves in the body. They found it can keep infection away for about four weeks with over ninety-five percent success. That is a bit better than SP-AQ even when children take all their doses. If the cabamiquine amount is less than two hundred milligrams, the shield fades after six weeks. At two hundred milligrams or more, the combo still beats the old treatment. The models also considered different weather patterns and how long the malaria season lasts.

If this single-dose plan is used in seasonal malaria programs, health workers might need fewer rounds of medicine. Spacing the doses farther apart could cut costs and still protect children. The results suggest the new combo is worth studying further in real trials. Fewer visits to the clinic could mean less stress for families